Cite

<atl>HA1004, an inhibitor of serine/threonine protein kinases, restores the sensitivity of thymic lymphomas to Ca2+-mediated apoptosis through a protein kinase A-independent mechanism

MLA

Matuszyk, Janusz, et al. “HA1004, an Inhibitor of Serine/Threonine Protein Kinases, Restores the Sensitivity of Thymic Lymphomas to Ca2+-Mediated Apoptosis through a Protein Kinase A-Independent Mechanism.” International Immunopharmacology, vol. 2, no. 4, Mar. 2002, p. 435. EBSCOhost, https://doi.org/10.1016/S1567-5769(01)00167-9.



APA

Matuszyk, J., Cebrat, M., Kalas, W., & Strzadala, L. (2002). HA1004, an inhibitor of serine/threonine protein kinases, restores the sensitivity of thymic lymphomas to Ca2+-mediated apoptosis through a protein kinase A-independent mechanism. International Immunopharmacology, 2(4), 435. https://doi.org/10.1016/S1567-5769(01)00167-9



Chicago

Matuszyk, Janusz, Malgorzata Cebrat, Wojciech Kalas, and Leon Strzadala. 2002. “HA1004, an Inhibitor of Serine/Threonine Protein Kinases, Restores the Sensitivity of Thymic Lymphomas to Ca2+-Mediated Apoptosis through a Protein Kinase A-Independent Mechanism.” International Immunopharmacology 2 (4): 435. doi:10.1016/S1567-5769(01)00167-9.